Current Opinion in Urology

Papers
(The TQCC of Current Opinion in Urology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Editorial introductions75
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies52
Research frontiers in urology51
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects47
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker28
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis27
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update23
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma23
The role of innovations in advancing urologic oncologic patient care20
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments20
Exploring the impact of artificial intelligence–enabled decision aids in improving patient inclusivity, empowerment, and education in urology: a systematic review by EAU endourology20
Tissue-based gene expression testing in localized prostate cancer19
Editorial introductions17
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder17
Editorial introductions16
Testicular cancer with small metastatic burden: optimal approach in 202415
Editorial introductions15
RNA-based urinary assays for non-muscle invasive bladder cancer15
Systemic immunotherapy for BCG unresponsive nonmuscle-invasive bladder cancer14
Applications used to minimize forgotten stents: a systematic review of the literature. Is it the dawn of a new era?13
Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations13
Sustainable practices in hospital and operating theaters13
Optimizing clinical risk stratification of localized prostate cancer12
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma12
Perioperative systemic therapy, current paradigm and ongoing clinical trials in upper tract urothelial cancer11
Sexually transmitted infections and the vaginal microbiome after vaginoplasty11
Risk of dementia associated with the use of anticholinergic medications: a review of recent literature11
Endourology at the crossroads of innovation: technology, artificial intelligence and patient-focused care – an EAU endourology perspective11
Oncolytic virus therapy for nonmuscle-invasive bladder cancer: current status and future directions11
Should endoscopic laser excision be offered as the first-line management for patients with eroded mesh? Outcomes of a systematic review of literature11
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects11
All about pulsed thulium:YAG laser: a systematic review from YAU Endourology and EAU Endourology11
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging10
Is there a role for metastasis-directed therapy in bladder cancer?10
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints10
Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors10
Metabolic syndrome, obesity and cancer risk10
The role of surgery for locally advanced urothelial cancers9
Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?9
Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities9
Advances in laser pulse modulations9
The role of radiotherapy in pelvic nodal recurrence following definitive treatment for prostate cancer9
Preoperative geriatric assessment of urological patients: a narrative review9
Update on classification of oncocytic neoplasms of the kidney9
Utility of augmented reality in endoscopic surgery for stones: European Association of Urology endourology up-to-date review9
Management of vaginoplasty canal complications9
Personalised medicine in urothelial carcinoma: where do we stand and what is the way to go?9
Brief update of the new WHO classification for urothelial carcinoma9
Histologic subtypes of urothelial carcinoma: an update9
Toxicities of taxane-based chemotherapy in prostate cancer8
Decoding germ cell tumours for clinicians8
Retrograde intra renal surgery and safety: pressure and temperature. A systematic review7
Sarcomatoid urothelial carcinoma: advances and challenges7
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors7
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes7
AI-powered radiomics: revolutionizing detection of urologic malignancies7
Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis7
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer7
Alternatives to whole gland treatment for localized prostate cancer: a review of novel focal therapies7
Editorial introductions7
Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma7
Patient-reported outcomes in genital gender-affirming surgery7
Preoperative patient optimization for endourological procedures: the current best clinical practice7
Upper tract urothelial carcinoma: conservative management - intraluminal adjuvant therapy, and surveillance7
MR-guided radiotherapy for prostate cancer: an inevitable transition?7
Percutaneous management of caliceal diverticula: a narrative review6
Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis6
Liquid biomarkers in prostate cancer: recent advancements and future directions6
Open versus robot-assisted surgery in reconstructive urology: lessons from vesicourethral anastomotic stenosis and radical cystectomy6
Lasers for benign prostatic hyperplasia (hybrid, blue diode, TFL, Moses). Which one to choose?6
Toxicities of radioligand and radioisotope therapy in prostate cancer: a systematic review and meta-analysis6
Inflammation and kidney stones: cause and effect?6
Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer6
Metastasis-directed therapy in oligometastatic and oligoprogressive renal cell carcinoma6
Use of genomic markers to improve epidemiologic and clinical research in urology6
Digital health innovations in urology: telemedicine, wearables, and mobile applications – a systematic review of literature6
The carbon footprint of modern imaging6
Advanced sperm tests and impact on clinical male factor management6
Medical therapy for male infertility6
Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer6
The use of MRI in urothelial carcinoma5
The role of surgical resection of the primary tumor in metastatic upper tract urothelial carcinoma: a systematic review and meta-analysis5
The environmental impacts of anesthesia5
Novel intravesical delivery systems for nonmuscle invasive bladder cancer5
Prevention, diagnosis, and treatment of urolithiasis in geriatric patients - differences, similarities and caveats in comparison to the general population5
Editorial: Future of kidney stone management5
Cost-effectiveness of serum, urine, and tissue-based prostate cancer biomarkers5
Organ storage in renal transplantation5
Pelvic pain syndromes5
Overlooked and underserved: how healthcare fails men in the pursuit of equity5
Does surgical removal of kidney stones help prevent the recurrence of urinary tract infections? A systematic review5
Graft and flap choices in anterior urethroplasty: oral mucosa and beyond5
Integration of novel artificial intelligence tools in pediatric urologic practice5
Metabolic evaluation: is there really a future?5
New technologies for nephron-sparing surgery in upper urinary tract cancers5
Preclinical models for bladder cancer therapy research5
Detection of urological cancers by the signature of organic volatile compounds in urine, from dogs to electronic noses5
What’s in a name? Why differentiation between biochemical recurrence and metastatic prostate cancer matters5
Next-gen minimally invasive surgical therapies for benign prostatic hyperplasia: innovations, selection, and best practices- a review from European Association of Urology endourology5
Genetics of testicular cancer: a review5
En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference?5
Ultra-hypofractionation for the treatment of macroscopic prostate bed recurrence: a focus on stereotactic radiotherapy and brachytherapy5
Editorial introductions5
Surgical management of testicular cancer with limited retroperitoneal disease5
Role of cytoreductive surgery in the era of immunotherapy5
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era5
0.091768026351929